Author

Bridget L. Sanford

Children's Hospital ColoradoORCID 0000-0002-2173-0198Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrew M. DonsoniD· 2 shared Ilango BalakrishnaniD· 2 shared Nathan A. DahliD· 2 shared Rajeev VibhakariD· 2 shared Senthilnath LakshmanachettyiD· 2 shared Siddhartha S. MitraiD· 2 shared Sujatha VenkataramaniD· 2 shared Adam L. GreeniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrew M. DonsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas

Senthilnath Lakshmanachetty, Kent A. Riemondy, Bridget L. Sanford, Andrew M. Donson, Vincent C. Chen, Ilango Balakrishnan, Eric W. Prince, Todd Cameron Hankinson, Nathan A. Dahl, Rajeev Vibhakar, Nicholas K. Foreman, Sujatha Venkataraman, Siddhartha S. Mitra

This study investigates how differential phagocytosis induced by RT or anti-CD47 therapy affects macrophage activation states in gliomas, showing that combination therapy reduces tumor growth and induces distinct macrophage states.

Journal for ImmunoTherapy of Cancer · Sep 1, 2025Peer-reviewedCancer Biology

Targeting Diffuse Midline Glioma with a novel anti-CD99 Antibody

Ilango Balakrishnan, Krishna P.C. Madhavan, Angela M. Pierce, Joshua Michlin, Breauna Brunt, Senthilnath Lakshmanachetty, Dong Wang, John A. DeSisto, Zachary James Nuss, Nathan L. Davidson, Faye M. Walker, Ammu Suresh, Andrew M. Donson, Bridget L. Sanford, Kenneth L. Jones, , Sujatha Venkataraman

This paper identifies CD99 as a therapeutic target in K27M+DMGs, showing that a novel anti-CD99 antibody reduces tumor growth and enhances radiation efficacy in preclinical models.

Cancer Research · May 27, 2025Peer-reviewedCancer Biology